Physician profile
Stephen M Canowitz
NPI 1174573224
$2,435.35
in general payments reported to CMS, 2019-2025
35 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.00 · 2020: $27.28 · 2021: $173 · 2022: $181 · 2023: $244 · 2024: $674 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $629.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $198.60 | 2024-2025 | Kisunla, Mounjaro |
| Paratek Pharmaceuticals, INC. | $170.91 | 2023-2025 | Nuzyra |
| Acadia Pharmaceuticals INC | $134.91 | 2024-2025 | Nuplazid |
| Amgen INC. | $128.22 | 2024-2025 | Krystexxa, Otezla, Repatha |
| Lucid Diagnostics INC. | $107.37 | 2022 | |
| Abbvie INC. | $101.81 | 2023-2025 | Ubrelvy |
| Smith+Nephew, INC. | $87.31 | 2024-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Stravix, Stravix Pl |
| Lundbeck LLC | $77.33 | 2025 | Rexulti |
| Pfizer INC. | $76.34 | 2023-2025 | |
| Glaxosmithkline, LLC. | $72.92 | 2022-2023 | Shingrix, Arexvy |
| Circassia INC. | $68.70 | 2025 | Niox |
| Teva Pharmaceuticals USA, INC. | $63.21 | 2024-2025 | Austedo Xr, Austedo Xr |
| Convatec INC. | $52.16 | 2023-2024 | |
| Ets Wound Care LLC | $46.32 | 2025 | Mirragen Advanced Wound Matrix |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $37.46 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.68 | 2023 | |
| Globus Medical, INC. | $33.11 | 2025 | Vyrsa V1 |
| Bayer Healthcare Pharmaceuticals INC. | $27.46 | 2024 | |
| Biocomposites INC | $25.19 | 2024 | |
| Exact Sciences Corporation | $25.08 | 2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.22 | 2025 | Caplyta |
| Medtronic, INC. | $22.41 | 2025 | Inceptiv |
| Bioventus LLC | $21.53 | 2024 | Exogen Ultrasound Bone Healing System |
| Otsuka America Pharmaceutical, INC. | $18.77 | 2024 | Nuedexta |
| E.R. Squibb & Sons, L.L.C. | $18.09 | 2025 | Camzyos |
| Stryker Corporation | $17.44 | 2023 | N/A, Actishield, Sonicanchor |
| Integra Lifesciences Corporation | $16.92 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $16.79 | 2024 | Bun-Yo-Matic |
| Biohaven Pharmaceuticals, INC. | $15.72 | 2021 | |
| Solventum Corporation | $13.70 | 2024 | Activ.A.C. |
| Merck Sharp & Dohme LLC | $13.57 | 2024 | Dificid |
| Abbott Laboratories | $13.28 | 2023 | Freestyle Libre 2 |
| Axsome Therapeutics, INC. | $12.64 | 2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Canowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.